Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Whitehall-Robins

This article was originally published in The Tan Sheet

Executive Summary

Children's multivitamin will be rebranded with characters from the Nickelodeon cable network's "Rugrats" series in times for a September launch. In addition to an advertising effort targeting the Rugrats multis, a new feature film is set for release. The popular cartoon characters replace Shamu, the Sea World killer whale, on the Centrum children's line. The move quickly follows the debut of Rexall Sundown's Pokemon children's multis (1"The Tan Sheet" Dec. 20, 1999, p. 3)

You may also be interested in...



Rexall Met-Rx Acquisition Brings Sport Supplement Marketing Power

Rexall Sundown's planned $108 mil. acquisition of Met-Rx Nutrition would give the vitamin, mineral and supplement powerhouse a strong foothold in the sports nutritional category and an enhanced retail presence in health food and fitness channels.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS091394

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel